Rapport Therapeutics (RAPP) Stock Chart & Stock Price History $23.83 -4.20 (-14.98%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Rapport Therapeutics Stock Price Performance The Rapport Therapeutics (RAPP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 22.54%, with a year-to-date return of 36.36%. In the past month, the stock has increased 66.25%, reflecting recent market activity. As of the latest close, Rapport Therapeutics traded at $28.03 with a market cap of $1.02 billion and volume of 1.71 million shares. Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+68.45%1 Month Performance+66.25%3 Month Performance+83.81%Year-To-Date Performance+36.36%1 Year Performance+22.54% RAPP Stock Chart for Wednesday, September, 10, 2025 RAPP Chart by TradingView Rapport Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/09/2025$31.47$28.03-10.93%$33.00$27.301.71 million shs$1.02 billion09/08/2025$14.36$31.47+119.15%$42.27$27.0513.85 million shs$1.15 billion09/05/2025$15.35$14.36-6.45%$16.00$14.21371,868 shs$524.14 million09/04/2025$15.04$15.35+2.06%$15.76$14.11164,559 shs$560.24 million09/03/2025$16.37$15.04-8.12%$16.98$14.84206,389 shs$548.96 million09/02/2025$17.63$16.37-7.15%$17.70$14.80531,035 shs$597.51 million09/01/2025$17.63$17.63$17.99$16.09387,001 shs$643.46 million08/29/2025$16.80$17.63+4.94%$17.99$16.09387,001 shs$643.46 million08/28/2025$14.97$16.80+12.22%$17.76$15.26478,948 shs$613.20 million08/27/2025$16.01$14.97-6.50%$16.03$14.79146,295 shs$546.41 million Get the Latest News and Ratings for RAPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/26/2025$14.63$16.01+9.43%$16.10$14.63427,329 shs$584.33 million08/25/2025$14.77$14.63-0.95%$14.96$14.3098,699 shs$534.00 million08/22/2025$14.93$14.77-1.07%$15.71$14.73182,176 shs$539.11 million08/21/2025$14.32$14.93+4.26%$15.23$13.90126,316 shs$544.95 million08/20/2025$14.24$14.32+0.56%$14.66$13.93101,808 shs$522.65 million08/19/2025$14.59$14.24-2.40%$14.75$13.86154,770 shs$519.76 million08/18/2025$14.70$14.59-0.75%$15.64$14.25134,121 shs$532.54 million08/15/2025$14.94$14.70-1.61%$16.41$14.65146,287 shs$536.55 million08/14/2025$15.60$14.94-4.23%$15.44$14.70109,059 shs$545.28 million08/13/2025$15.54$15.60+0.39%$16.13$15.42145,383 shs$569.40 million08/12/2025$14.34$15.54+8.34%$15.87$14.28213,509 shs$567.21 million08/11/2025$14.55$14.34-1.42%$15.49$14.09165,822 shs$523.53 million Related Companies IMVT Stock Chart CPRX Stock Chart KNSA Stock Chart TARS Stock Chart OGN Stock Chart ALVO Stock Chart CNTA Stock Chart DNLI Stock Chart IBRX Stock Chart AGIO Stock Chart Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RAPP) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RAPP Stock Alerts